C07D 239/18
With hetero atoms attached to said nitrogen atoms, except nitro radicals
Official title: with hetero atoms attached to said nitrogen atoms, except nitro radicals, e.g. hydrazine radicals
C07D239/18 (With hetero atoms attached to said nitrogen atoms, except nitro radicals) appears on 47 US grants and 13 published applications in this corpus.
Search patents in C07D- Granted patents
- 47
- Published applications
- 13
- Assignees
- 21
- Inventors
- 89
- Latest grant
- 19 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 4 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 3 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 1 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 2 | 0 |
| 2023 | 0 | 0 |
| 2024 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Inhibition of Olig2 activity19 Nov 2024US 12,145,913 B2Curtana Pharmaceuticals, Inc.
- Therapeutic compounds11 Jun 2024US 12,006,294 B2Regents of the University of Minnesota
- Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR630 Aug 2022US 11,426,397 B2Takeda Pharmaceutical Company Limited
- Inhibition of OLIG2 activity8 Feb 2022US 11,242,323 B2Curtana Pharmaceuticals, Inc.
- Preparation and use of silver sulfadiazine-immobilized fillers11 Aug 2020US 10,736,821 B2University of Massachusetts
- Inhibition of olig2 activity19 Aug 2021US 2021/0253535 A1Curtana Pharmaceuticals, Inc.
- Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of gpr63 Dec 2020US 2020/0375969 A1Takeda Pharmaceutical Company Limited
- Inhibition of olig2 activity26 Dec 2019US 2019/0389812 A1Curtana Pharmaceuticals, Inc.
- Therapeutic compounds31 Oct 2019US 2019/0330157 A1Regents of the University of Minnesota
- Therapeutic compounds16 Aug 2018US 2018/0230105 A1
Most cited
By later US patents
- Heterocyclic compounds114US 4,742,060 ANihon Tokushu Noyaku Seizo K. K. · 1988
- PDE4B inhibitors and uses therefor63US 7,585,859 B2Plexxikon Inc. · 2009
- Heterocyclic thiazole compounds48US 4,845,106 ANihon Tokushu Noyaku Seizo K. K. · 1989
- Heterocyclic compounds39US 5,298,507 ANihon Bayer Agrochem K. K. · 1994
- Heterocyclic compounds36US 5,461,167 ANihon Bayer Agrochem K. K. · 1995